{"id":"https://openalex.org/W7951465","doi":null,"title":"Aloin, cinnamic acid and sophorcarpidine are potent inhibitors of tyrosinase.","display_name":"Aloin, cinnamic acid and sophorcarpidine are potent inhibitors of tyrosinase.","alternate_titles":[],"publication_year":2002,"publication_date":"2002-12-01","ids":{"openalex":"https://openalex.org/W7951465","mag":"7951465","pmid":"https://pubmed.ncbi.nlm.nih.gov/12622939"},"language":"en","primary_location":{"id":"mag:7951465","doi":null,"is_oa":true,"landing_page_url":"https://europepmc.org/article/MED/12622939","pdf_url":null,"source":{"id":"https://openalex.org/S22240167","display_name":"Chinese Medical Journal","issn_l":"0366-6999","issn":["0366-6999","2542-5641"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Medical Journal","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W7951465"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://europepmc.org/article/MED/12622939","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100763145","display_name":"Cheng Tan","orcid":"https://orcid.org/0000-0002-8764-2078","observed_orcids":["https://orcid.org/0000-0002-8764-2078"]},"institutions":[{"id":"https://openalex.org/I4210152119","display_name":"Jiangsu Province Hospital","ror":"https://ror.org/04py1g812","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210152119"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Cheng Tan","raw_affiliation_strings":["Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. tancheng@jschina.com.cn","Department of Dermatology, First Affiliated Hospital of Nanjing Medical University,Nanjing 210029, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. tancheng@jschina.com.cn","institution_ids":["https://openalex.org/I4210152119"]},{"raw_affiliation_string":"Department of Dermatology, First Affiliated Hospital of Nanjing Medical University,Nanjing 210029, China","institution_ids":["https://openalex.org/I4210152119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101695274","display_name":"Wen\u2010Yuan Zhu","orcid":"https://orcid.org/0000-0002-9364-781X","observed_orcids":["https://orcid.org/0000-0002-9364-781X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenyuan Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5076757832","display_name":"Yan Zhen Lu","orcid":"https://orcid.org/0000-0002-7718-7999","observed_orcids":["https://orcid.org/0000-0002-7718-7999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Lu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0821,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.34630616,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"115","issue":"12","first_page":"1859","last_page":"1862"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12257","display_name":"Bioactive natural compounds","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tyrosinase-inhibition","display_name":"tyrosinase inhibition","score":0.9430000185966492},{"id":"https://openalex.org/keywords/aloin","display_name":"aloin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cinnamic-acid","display_name":"cinnamic acid","score":1.0},{"id":"https://openalex.org/keywords/hyperpigmentation","display_name":"hyperpigmentation","score":0.8389999866485596},{"id":"https://openalex.org/keywords/skin-lightening-products","display_name":"skin whitening products","score":0.8880000114440918},{"id":"https://openalex.org/keywords/natural-compounds","display_name":"natural compounds","score":0.48899999260902405},{"id":"https://openalex.org/keywords/uncompetitive-inhibition","display_name":"uncompetitive inhibition","score":0.7300000190734863},{"id":"https://openalex.org/keywords/mixed-inhibition","display_name":"mixed-type inhibition","score":0.984000027179718},{"id":"https://openalex.org/keywords/l-dopa-oxidation","display_name":"L-DOPA oxidation","score":0.7730000019073486},{"id":"https://openalex.org/keywords/hydroquinone","display_name":"hydroquinone","score":0.6800000071525574},{"id":"https://openalex.org/keywords/farrerol","display_name":"farrerol","score":0.8980000019073486}],"concepts":[{"id":"https://openalex.org/C2778831176","wikidata":"https://www.wikidata.org/wiki/Q164785","display_name":"Cinnamic acid","level":2,"score":0.9537459015846252},{"id":"https://openalex.org/C87554066","wikidata":"https://www.wikidata.org/wiki/Q85942926","display_name":"Tyrosinase","level":3,"score":0.9288133382797241},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7778129577636719},{"id":"https://openalex.org/C2777550763","wikidata":"https://www.wikidata.org/wiki/Q419164","display_name":"Hydroquinone","level":2,"score":0.7133429050445557},{"id":"https://openalex.org/C2779538156","wikidata":"https://www.wikidata.org/wiki/Q416285","display_name":"Kojic acid","level":4,"score":0.526803731918335},{"id":"https://openalex.org/C2776728111","wikidata":"https://www.wikidata.org/wiki/Q1641068","display_name":"Hyperpigmentation","level":2,"score":0.4727797508239746},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.45899465680122375},{"id":"https://openalex.org/C2911106216","wikidata":"https://www.wikidata.org/wiki/Q164785","display_name":"Cinnamates","level":2,"score":0.4256054759025574},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.37727785110473633},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.16549468040466309}],"mesh":[{"descriptor_ui":"D002934","descriptor_name":"Cinnamates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003358","descriptor_name":"Cosmetics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004642","descriptor_name":"Emodin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004642","descriptor_name":"Emodin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014442","descriptor_name":"Monophenol Monooxygenase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017495","descriptor_name":"Hyperpigmentation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D028321","descriptor_name":"Plant Preparations","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"mag:7951465","doi":null,"is_oa":true,"landing_page_url":"https://europepmc.org/article/MED/12622939","pdf_url":null,"source":{"id":"https://openalex.org/S22240167","display_name":"Chinese Medical Journal","issn_l":"0366-6999","issn":["0366-6999","2542-5641"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Medical Journal","raw_type":null},{"id":"pmid:12622939","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12622939","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chinese medical journal","raw_type":"Journal Article"}],"best_oa_location":{"id":"mag:7951465","doi":null,"is_oa":true,"landing_page_url":"https://europepmc.org/article/MED/12622939","pdf_url":null,"source":{"id":"https://openalex.org/S22240167","display_name":"Chinese Medical Journal","issn_l":"0366-6999","issn":["0366-6999","2542-5641"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Medical Journal","raw_type":null},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.46810001134872437}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2354819894","https://openalex.org/W2364222462","https://openalex.org/W2981528023","https://openalex.org/W3120431834","https://openalex.org/W2919242331","https://openalex.org/W7134057163","https://openalex.org/W2485074093","https://openalex.org/W3107843870","https://openalex.org/W3170008684","https://openalex.org/W2325804088"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,17,28,43,50,56,61,94],"effects":[4],"of":[5,13,19,30,46,49,76,78,83,101,121],"aloin,":[6],"cinnamic":[7,68,84,116,133],"acid":[8,85],"and":[9,33,71,93,119,132],"15":[10],"other":[11],"kinds":[12],"natural":[14],"chemicals":[15],"on":[16],"activity":[18,38,110],"tyrosinase,":[20],"in":[21,27],"order":[22],"to":[23,55,60,130],"provide":[24],"lightening":[25],"agents":[26],"treatment":[29],"hyperpigmentation":[31],"disorders":[32],"cosmetic":[34],"additives.":[35],"METHODS:":[36],"Tyrosinase":[37,109],"was":[39,52],"estimated":[40],"by":[41,115],"measuring":[42],"oxidation":[44],"rate":[45],"L-dopa.":[47],"Inhibition":[48],"enzyme":[51],"deduced":[53],"according":[54],"Lineweaver-Burk":[57],"plots":[58],"compared":[59,129],"control.":[62],"RESULTS:":[63],"Cadabine,":[64],"paeonal,":[65],"farrerol,":[66],"evodin,":[67],"acid,":[69,117,134],"aloin":[70,90,118,131],"sophorcarpidine":[72,123],"had":[73],"different":[74],"levels":[75],"inhibition":[77],"tyrosinase.":[79],"The":[80],"inhibitory":[81],"rates":[82],"(2":[86,91],"mmol/L,":[87],"0.5":[88],"mmol/L),":[89],"mmol/L)":[92,104],"rest":[95],"were":[96],"significantly":[97],"higher":[98],"than":[99],"that":[100],"hydroquinone":[102],"(0.5":[103],"(P":[105],"<":[106],"0.05).":[107],"CONCLUSIONS:":[108],"can":[111],"be":[112],"greatly":[113],"inhibited":[114],"sophorcarpidine,":[120],"which":[122,135],"functions":[124],"as":[125],"an":[126],"uncompetitive":[127],"inhibitor,":[128],"are":[136],"mixed-type":[137],"inhibitors.":[138]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7951465","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
